- Home
- IPGP vs SRRK Comparison
IPGP vs SRRK Comparison
Compare IPGP & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPGP
- SRRK
- Stock Information
- Founded
- IPGP 1990
- SRRK 2012
- Country
- IPGP United States
- SRRK United States
- Employees
- IPGP N/A
- SRRK N/A
- Industry
- IPGP Semiconductors
- SRRK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IPGP Technology
- SRRK Health Care
- Exchange
- IPGP Nasdaq
- SRRK Nasdaq
- Market Cap
- IPGP 3.3B
- SRRK 2.9B
- IPO Year
- IPGP 2006
- SRRK 2018
- Fundamental
- Price
- IPGP $58.63
- SRRK $32.87
- Analyst Decision
- IPGP Buy
- SRRK Strong Buy
- Analyst Count
- IPGP 7
- SRRK 6
- Target Price
- IPGP $80.25
- SRRK $42.17
- AVG Volume (30 Days)
- IPGP 320.6K
- SRRK 1.6M
- Earning Date
- IPGP 05-06-2025
- SRRK 05-06-2025
- Dividend Yield
- IPGP N/A
- SRRK N/A
- EPS Growth
- IPGP N/A
- SRRK N/A
- EPS
- IPGP N/A
- SRRK N/A
- Revenue
- IPGP $977,134,000.00
- SRRK N/A
- Revenue This Year
- IPGP $2.65
- SRRK N/A
- Revenue Next Year
- IPGP $7.28
- SRRK $601.05
- P/E Ratio
- IPGP N/A
- SRRK N/A
- Revenue Growth
- IPGP N/A
- SRRK N/A
- 52 Week Low
- IPGP $48.59
- SRRK $6.76
- 52 Week High
- IPGP $92.21
- SRRK $46.98
- Technical
- Relative Strength Index (RSI)
- IPGP 49.85
- SRRK 52.61
- Support Level
- IPGP $51.06
- SRRK $30.93
- Resistance Level
- IPGP $60.39
- SRRK $33.01
- Average True Range (ATR)
- IPGP 2.30
- SRRK 1.72
- MACD
- IPGP 0.90
- SRRK 0.62
- Stochastic Oscillator
- IPGP 72.05
- SRRK 77.13
About IPGP IPG Photonics Corporation
IPG Photonics Corp is a vertically integrated developer and manufacturer of high-performance fiber lasers, fiber amplifiers, and diode lasers, which are used in diverse applications in the manufacturing, automotive, industrial, aerospace, semiconductor, and consumer end markets. A large majority of the firm's revenue is derived from materials processing applications for fiber lasers, including cutting and welding, marking and engraving, and micro-processing. The company generates a majority of its revenue from China and also has its presence in North America, Japan, Germany, and other markets.
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.